Immunoglobulin fractions have been successfully used in vivo for the treatment of iIInesses such as chronic diarrhea in the newborn. When used to fortify human breast rnilk, it is important that the milk immunoglobulins remain unaltered during the protein concentration process. The purpose of the present study was to evaluate changes in the quantity of IgA. IgG and IgM immunoglobulins after concentration of human milk proteins by an ultrafiltration membrane technique. lrnrnunoglobulins present in human milk and the retentate obtained after ultrafiltration of the milk were analyzed by ELISA and gel filtration. The recovery of immunoglobulins in the retentate obtained from ultrafiltration was high: 100%, 70% and 60% of the total IgA. IgG and IgM. respectively. ELISA showed that IgA was the major immunoglobulin present in human milk. Gel filtration analysis showed thatthe IgA immunoglobulins were entirely in the form of dimeric secretory IgAs both in the milk and in the retentate. Ultrafiltration appears to be a useful technique for preparing immunoglobulin-enriched human milk fractions. 
INTRODUCTION
Human milk is still considered to be the best tolerated form of milk for the newborn infant (Ogra and Greene, 1982) , but is nutritionally inadequate for the very low birthweight neonate who requires more protein than is available in human breast miik for the catch-up growth phase characteristic of these infants. For this reason, human milk protein concentrates have baen developed for the fortification of breast milk (Lucas et al, 1980; Voyer et al, 1984) . Human milk is also known to contain protective factors against infection and disease in the newborn (Pitt, 1979) , including imrnunoqlobutlns. For example, a bacteriostatic effect of milk protein fractions fortified in secretory immunoglobulin A and/or lactoferrin has been demonstrated in vitro (Bullen et al, 1972; Spik et al, 1978; Arnold et al, 1980) . Such protein fractions have also been used with success in vivo in the treatment of neonatal diarrhea (Navarro et al, 1983; Spik etaI, 1984) . Therefore, it is possible that fortifying human breast milk with human milk protein fractions could not only be useful in the neonatal unit for the feeding of very low birthweight neonates, but also in 9astroen-terology and pediatrie surgery units where it could serve as a potential therapeutic aid. In regard to the latter, it is important that the milk immunoglobulins remain unaltered after protein concentration. The purpose of the present study was to 'evaluate changes in the quantity of immunoglobulins A, Gand M (lgA, IgG, IgM) after concentratlon of human milk proteins by an ultrafiltration membrane technique (Maubois and Brulé, 1982; Maubois, 1984) . Maynard et al (1989) . Thirty-six kg of retentate was obtained from the ultrafiltration.
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MATERIALS AND METHOOS
Milk collection and uftraflltrfJion
After 2 successive centrifugations of the RPM (1 600 g, 4 oC, 30 min), the fat layer was removed. The defatted RPM and retentate were then ultracentrifuged at 100 000 9 for 2 h at 4 oC. The supernatants were aspirated and aliquoted, whereas the pellets (which contain casein) were discarded. The total immunoglobulin response was quanntatively recovered ln the supernatant according to ELISA.
Fast protein Iiquid chromatography
Fast protein liquid chromatography (FPLC) was performed with an LCC 500 system (Pharmacia, Saint-Quentin-en-Yvelines, France) equipped with a Superose 12 (Pharmacia) gel filtration column and a UV detector set at a wavelenqth of 280 nm. The column was eluted with a 50 mM PBS butter (pH 7.0) at a tlow rate of 0.4 mVmin. After filtration through a o.zz-um filter, 200 III of each sample were injected into the column and the eluent was collected in 0.8-m1fractions.
Enzyme Iinked immunosorbent assay (ELISA)
For the ELISA of IgA, IgG and IgM. microliter plates for micro-ELISA (Nunc) were used as the solid-phase carrier. Goat antibody anti-human IgG (Biosys), anti-human IgM (Miles) and antihuman IgA (Behring) were applied at 100 ill/weil in a coupling buffer (60 mM bicarbonate buffer, pH 9.8) at dilutions of 1/2 000, 1/1 500, and 1/ 2000, respectively. After an overnight incubation at 4 oC, plates were washed in PBS-Tween buffer (phosphate-buffered saline, pH 7.4, containing 0.05% Tween 20). Test samples were then incubated in duplicate in 100 ill/weil PBSTween at 37 oC for 90 min. After washing with PBS-Tween buffer, plates were incubated with goat antibody peroxidase conjugate (100 ill/weil) at 37 oC for 1 h more. Anti-lgA (Biosys), anti-lgG (Biosys) and anti-lgM (Miles) were previously diluted in PBS-Tween at dilutions of 1/3 000, 1/ 6000 and 1/4 000, respectively. After the final wash, peroxidase activity was detected with 100 ill/weil orthophenylenediamine substrate (Prolabol freshly dissolved at 0.4 mg/ml in citrate butfer (50 mM, pH 5.0). After 15 min, the reaction was stopped by addition of 5 N sulfuric acid (50 ill/weil), and quantified by measurement of absorbance at a wavelength of 490 nm on a microplate autoreader (Bio-Tek instrument). Standard curves for IgA, IgM and IgG were established with a standard (Behring, RueilMalmaison, France).
MILK PREPARATION
RESUL TS AND DISCUSSION
The concentration of IgG, IgM and IgA was measured by ELISA both in the RPM and the retentate obtained after ultrafiltration ( lin present in the human breast milk. After ultrafiltration, the Ig fractions remained in the retentate with a 5-9 concentration yield relative to the RPM. Furthermore, 100, 70 and 60% of the total IgA, IgG and IgM respectively was recovered in the retentate.
Chramatography of the supernatants obtained from the ultracentrifugation of RPM and of the retentate was perlormed by gel filtration (figs 2, 3). In order to differentiate dimeric secretory IgA (lgAs) from monomeric IgA, the collected fractions were analysed by ELISA. A standard serum (Behring), which contained both monomeric IgA (160 000 Da) that eluted at 8.8 ml and dimeric secretory IgA (420 000 Da) that eluted at 4.8 ml, was used as the standard (fig 2A) . Under the same conditions, IgA ELISA monitoring of the gel filtration fractions from RPM ( fig 2B) and retentate ( fig 2C) showed only one peak of IgAs eluted at 4.8 ml. Monitoring of RPM and retentate at an absorbance of 280 nm indicated a major peak of oe-lactalbumln (14 000 Da) eluted at 12 ml. IgG and IgM ELISA monitoring of the gel filtration fractions indicated that both IgG and IgM were eluted in single peaks at 10 ml and 6 ml, respectively, in the raw pooled milk ( fig 3A) and retentate ( fig 3B) .
The current work confirms that IgA is the major Ig in human milk and is present entirely in a dimeric secretory form (Hanson et al, 1973; McClelland, 1982; Woodhouse et al, 1988) . A significant amount of the Ig fraction of human milk can be recovered in the retentate obtained after ultrafiltration of the milk. IgA is recovered most efficiently from the retentate where it remains in its dimeric secretory form. These results indicate that ultrafiltration could be a useful technique for the preparation of Ig-enriched milk fractions. However, the conditions allowing efficient sterilization of such a product without alteration of the Ig fraction need to be established before it can be used as a therapeutic aidin the treatment of iIIness in very low birthweight neonates. 
Profil des concentrations en IgG et IgM dosées par technique ELISA après chromatographie FPLC sur colonne Superose 12 du lait cru (A) et du rétentat (B).
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